[Schizophrenia and neural transmission: an excess of analogical treatment?].
Tassin
J P
JP
Chaire de Neuropharmacologie INSERM U.114, Collège de France, Paris.
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D001931:Brain Mapping; D006801:Humans; D018377:Neurotransmitter Agents / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology; D012565:Schizophrenic Psychology; D009435:Synaptic Transmission / Q000187:drug effects* / Q000502:physiology; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D018377:Neurotransmitter Agents